SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001415889-24-013998
Filing Date
2024-05-21
Accepted
2024-05-21 17:38:17
Documents
1
Period of Report
2023-08-10

Document Format Files

Seq Description Document Type Size
1 form3a-05212024_090509.html 3/A  
1 form3a-05212024_090509.xml 3/A 3331
  Complete submission text file 0001415889-24-013998.txt   4913
Mailing Address 6272 WEST 91ST AVENUE WESTMINSTER CO 80031
Business Address 6272 WEST 91ST AVENUE WESTMINSTER CO 80031 415 336 8917
TriSalus Life Sciences, Inc. (Issuer) CIK: 0001826667 (see all company filings)

IRS No.: 853009869 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)

Mailing Address C/O TRISALUS LIFE SCIENCES, INC. 6272 W. 91ST AVENUE WESTMINSTER CO 80031
Business Address
Martin George Kelly (Reporting) CIK: 0001982607 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-39813 | Film No.: 24970925